Literature DB >> 11923879

Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.

Ana Hatagima1.   

Abstract

Epidemiological studies have estimated that approximately 80% of all cancers are related to environmental factors. Individual cancer susceptibility can be the result of several host factors, including differences in metabolism, DNA repair, altered expression of tumor suppressor genes and proto-oncogenes, and nutritional status. Xenobiotic metabolism is the principal mechanism for maintaining homeostasis during the body's exposure to xenobiotics. The balance of xenobiotic absorption and elimination rates in metabolism can be important in the prevention of DNA damage by chemical carcinogens. Thus the ability to metabolize and eliminate xenobiotics can be considered one of the body's first protective mechanisms. Variability in individual metabolism has been related to the enzymatic polymorphisms involved in activation and detoxification of chemical carcinogens. This paper is a contemporary literature review on genetic polymorphisms involved in the metabolism of endocrine disruptors potentially related to cancer development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923879     DOI: 10.1590/s0102-311x2002000200002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  6 in total

1.  Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.

Authors:  Ya-Ping Luo; Han-Chun Chen; Md Asaduzzaman Khan; Fang-Zhi Chen; Xin-Xing Wan; Bo Tan; Fang-Dan Ou-Yang; Dian-Zheng Zhang
Journal:  Tumour Biol       Date:  2010-09-29

2.  Polymorphisms of CYP1A1, GSTM1 and GSTT1 Loci as the Genetic Predispositions of Oral Cancers and Other Oral Pathologies: Tobacco and Alcohol as Risk Modifiers.

Authors:  Sumana Chatterjee; Soujatya Dhar; Bani Sengupta; Ashish Ghosh; Manas De; Sumit Roy; Sila Chakrabarti
Journal:  Indian J Clin Biochem       Date:  2010-08-25

3.  CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.

Authors:  Feng-mao Huang; Han-chun Chen; Md Asaduzzaman Khan; Fu-lan Yang; Xin-xing Wan; Ai-hua Xu; Fang-dan Ou-yang; Dian-zheng Zhang
Journal:  Med Oncol       Date:  2013-03-08       Impact factor: 3.064

4.  Dietary benzo(a)pyrene and fetal growth: effect modification by vitamin C intake and glutathione S-transferase P1 polymorphism.

Authors:  Talita Duarte-Salles; Michelle A Mendez; Eva Morales; Mariona Bustamante; Agueda Rodríguez-Vicente; Manolis Kogevinas; Jordi Sunyer
Journal:  Environ Int       Date:  2012-05-05       Impact factor: 9.621

5.  Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis.

Authors:  Haitao Liu; Jinlin Jia; Xuemei Mao; Zhiyong Lin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Association of CYP3A5*3 and CYP1A1*2C Polymorphism with Development of Acute Myeloid Leukemia in Egyptian Patients

Authors:  Nahed Abd El Wahab; Nevine F Shafik; Roxan E Shafik; Sherin A Taha; Hanan E Shafik; Amira D Darwish
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.